Suchergebnisse - "Amin, Alpesh"

PubPharm (15)

1

Risk of stroke/systemic embolism, major bleeding, and associated costs in non-valvular atrial fibrillation patients who initiated apixaban, dabigatran, or rivaroxaban compared with warfarin in the United States medicare population : updated analysis

enthalten in: Current medical research and opinion | 2022

von Amin, A. | Keshishian, A. | Hines, D. | +6

2

Effectiveness and Safety of Dabigatran Compared to Vitamin K Antagonists in Non-Asian Patients with Atrial Fibrillation : A Systematic Review and Meta-Analysis

enthalten in: Clinical drug investigation | 2021

von Escobar, C. | Barrios, V. | Lip, G. | +5

ErratumIn: Clin Drug Investig. 2022 Mar;42(3):279-280. - PMID 35157250

3

Comparative clinical outcomes between direct oral anticoagulants and warfarin among elderly patients with non-valvular atrial fibrillation in the CMS medicare population

enthalten in: Journal of thrombosis and thrombolysis | 2019

von Amin, A. | Keshishian, A. | Dina, O. | +8

ErratumIn: J Thromb Thrombolysis. 2021 Feb;51(2):552-558. - PMID 32564179

4

Comparative clinical outcomes between direct oral anticoagulants and warfarin among elderly patients with non-valvular atrial fibrillation in the CMS medicare population

enthalten in: Journal of thrombosis and thrombolysis | 2019

von Amin, A. | Keshishian, A. | Dina, O. | +8

5

Comparative clinical outcomes between direct oral anticoagulants and warfarin among elderly patients with non-valvular atrial fibrillation in the CMS medicare population

enthalten in: Journal of thrombosis and thrombolysis | 2019

von Amin, A. | Keshishian, A. | Dina, O. | +8

6

Comparative clinical outcomes between direct oral anticoagulants and warfarin among elderly patients with non-valvular atrial fibrillation in the CMS medicare population

enthalten in: Journal of thrombosis and thrombolysis | 2019

von Amin, A. | Keshishian, A. | Dina, O. | +8

7

Effectiveness and safety of oral anticoagulants in older adults with non-valvular atrial fibrillation and heart failure

enthalten in: PloS one | 2019

von Amin, A. | Garcia Reeves, A. | Li, X. | +10

8

Risk of stroke/systemic embolism, major bleeding and associated costs in non-valvular atrial fibrillation patients who initiated apixaban, dabigatran or rivaroxaban compared with warfarin in the United States Medicare population

enthalten in: Current medical research and opinion | 2017

von Amin, A. | Keshishian, A. | Trocio, J. | +8

9

Comparison of differences in medical costs when new oral anticoagulants are used for the treatment of patients with non-valvular atrial fibrillation and venous thromboembolism vs warfarin or placebo in the US

enthalten in: Journal of medical economics | 2015

von Amin, A. | Bruno, A. | Trocio, J. | +2

10

Target-specific oral anticoagulants and the hospitalist

enthalten in: Hospital practice (1995) | 2015

von Deitelzweig, S. | Amin, A.